MedTrace Logo

MDD(Mild Cognitive Impairment Delirium Dementia) Cohort

NCT05113446 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2022-08-01

No results posted yet for this study

Summary

* Identify the degree of delirium in subjects with mild cognitive impairment and find the risk factors of delirium. Mortality, hospital stay, and medical expenses are analyzed as clinical consequences related to delirium incidence.
* Dementia conversion rate and conversion period of subjects with mild cognitive impairment with delirium and it identifies the effect of delirium on dementia conversion.
* Develop an AI(Artificial intelligence) algorithm for predicting dementia transition in subjects with mild cognitive impairment based on the research results of the 1st, 2nd, and 3rd years.

Conditions

Interventions

DIAGNOSTIC_TEST

Delirium assessment using S-CAM

Twice a day, the rounds of nurses in shifts, 8:00 am - 10:00 am, 4:00 pm - 6:00 pm Trained research assistants assessed delirium using S-CAM

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-10-31
Completion
2025-12-31

Countries

  • South Korea

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05113446 on ClinicalTrials.gov